Nadira Ruzehaji
INSERM U1016, 27 Rue Du Faubourg Saint Jacques
Paris, 75014, France
Paris, 75014, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Retraction Note: Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis.
Journal: Arthritis research & therapy
Published: November 14, 2023
OX40L blockade protects against inflammation-driven fibrosis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 15, 2016
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis.
Journal: Annals of the rheumatic diseases
Published: July 10, 2015
Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis.
Journal: Mediators of inflammation
Published: June 29, 2015
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis.
Journal: Annals of the rheumatic diseases
Published: June 04, 2015
Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis.
Journal: Arthritis research & therapy
Published: December 10, 2014
Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis.
Journal: Arthritis research & therapy
Published: May 04, 2014
The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: June 10, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026